Clinical trial

Application of Different Modes of Esketamine Administration in Pediatric Day Circumcision

Name
2023-YKL01-(ke11)
Description
To explore the application of different administration modes of esketamine in pediatric day circumcision, in order to find an anesthesia scheme more suitable for day pediatric circumcision.
Trial arms
Trial start
2023-04-02
Estimated PCD
2023-05-15
Trial end
2023-06-01
Status
Not yet recruiting
Treatment
Esketamine of single injection
Single group: give esketamine 0.75 mg/kg at the time of induction
Arms:
single group
Other names:
A single injection of esketamine at the time of anesthesia induction
Esketamine of Intermittent injection
Intermittent group: give esketamine 0.5mg/kg during anesthesia induction, and during the measuring ring esketamine 0.25mg/kg was given again
Arms:
intermittent group
Other names:
A Intermittent injection of esketamine at the time of anesthesia induction
Size
70
Primary endpoint
One-time success rate of anesthesia
During surgery
Eligibility criteria
Inclusion Criteria: * American Society of Anesthesiologists (ASA) class I and II children * Age 5-12 years * Foreskin cerclage is proposed * No history of upper respiratory tract infection in the past two weeks * Obtain the consent of the child's family Exclusion Criteria: * Hepatic and renal insufficiency, coagulation dysfunction * Those who are allergic to esketamine * History of cognitive impairment * epilepsy * other psychiatric and neurological disorders
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['NA'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'primaryPurpose': 'OTHER', 'maskingInfo': {'masking': 'DOUBLE', 'whoMasked': ['PARTICIPANT', 'OUTCOMES_ASSESSOR']}}, 'enrollmentInfo': {'count': 70, 'type': 'ESTIMATED'}}
Updated at
2023-04-13

1 organization

1 product

1 indication

Product
Esketamine
Indication
Pain